An OHSS-Free Clinic by segmentation of IVF treatment

Human Reproduction

Volumn 26, Issue 10, 2011, Pages 2593-2597

  Devroey, Paul ^a   Polyzos, Nikolaos P ^a   Blockeel, Christophe ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

GnRH agonist; GnRH antagonist; OHSS; Ovarian stimulation; vitrification

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; PROGESTERONE;

CORPUS LUTEUM; CRYOPRESERVATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MECHANISM; EMBRYO TRANSFER; ENDOMETRIUM; FERTILIZATION IN VITRO; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; LIVE BIRTH; LOW DRUG DOSE; LUTEAL PHASE; MATERNAL WELFARE; MEDICAL ETHICS; MENTAL STRESS; META ANALYSIS (TOPIC); OOCYTE; OOCYTE MATURATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PRACTICE GUIDELINE; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT; VITRIFICATION;

EID: 80052902532     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der251     Document Type: Review

References (57)

1. Abdalla HI, Ah-Moye M, Brinsden P, Howe DL, Okonofua F, Craft I. The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilisation program. Fertil Steril 1987;48:958-963. (Pubitemid 18008201)
2. AbdelHafez FF, Desai N, Abou-Setta AM, Falcone T, Goldfarb J. Slow freezing, vitrification and ultra-rapid freezing of human embryos: a systematic review and meta-analysis. Reprod Biomed Online 2010; 20:209-222.
3. Abramov Y, Elchalal U, Schenker JG. Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril 1998;70:1070-1076. (Pubitemid 28546233)
4. Abramov Y, Elchalal U, Schenker JG. Pulmonary manifestations of severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril 1999;71:645-651. (Pubitemid 29149413)
5. Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Can fresh embryo transfers be replaced by cryopreserved-thawed embryo transfers in assisted reproductive cycles? A randomised controlled trial. J Assist Reprod Genet 2010;27:357-363.
6. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotropin-releasing hormone antagonists for assisted conception. Cochrane Database Sys Rev 2006;19:CD001750.
7. Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, Abou-Setta AM. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2011;11:CD001750.
8. Balaban B, Urman B, Ata B, Isiklar A, Larman MG, Hamilton R, Gardner DK. A randomised controlled study of human Day 3 embryo cryopreservation by slow freezing or vitrification: vitrification is associated with higher survival, metabolism and blastocyst formation. Hum Reprod 2008;23:1976-1982.
9. Bewley S, Foo L, Braude P. Adverse outcomes from IVF. BMJ 2011; 342:d436.
10. Borm G, Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 2000;15:1877. (Pubitemid 30636089)
11. Braat DD, Schutte JM, Bernardus RE, Mooij TM, van Leeuwen FE. Maternal death related to IVF in the Netherlands 1984-2008. Hum Reprod 2010;25:1782-1786.
12. Centre for Disease Control and Prevention,. Assisted Reproductive Technology Report, 2008.
13. Cobo A, Kuwayama M, Pérez S, Ruiz A, Pellicer A, Remoh́ý J. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril 2008; 89:1657-1664. (Pubitemid 351749628)
14. Cobo A, Meseguer M, Remoh́ý J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomised, controlled, clinical trial. Hum Reprod 2010;25:2239-2246.
15. Confidential Enquiry into Maternal and Child Health. Saving mothers' lives: reviewing maternal deaths to make motherhood safer 2003-2005. VII th report, 2007.
16. Courbiere B, Oborski V, Braunstein D, Desparoir A, Noizet A, Gamerre M. Obstetric outcome of women with in vitro fertilisation pregnancies hospitalised for ovarian hyperstimulation syndrome: a case-control study. Fertil Steril 2011;95:1629-1632.
17. Cunha-Filho JS, Samama M, Fanchin R, Righini C, Kadoch IJ, Frydman R, Olivennes F. Clinical and laboratory evaluation of hospitalised patients with severe ovarian hyperstimulation syndrome. Reprod Biomed Online 2003;6:448-451. (Pubitemid 36849806)
18. de Mouzon J, Goossens V, Bhattacharya S, Castilla JA, Ferraretti AP, Korsak V, Kupka M, Nygren KG, Andersen A. Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod 2010;25:1851-1862.
19. Delvigne A. Symposium: Uupdate on prediction and management of OHSS. Epidemiology of OHSS. Reprod Biomed Online 2009;19:8-13.
20. Devroey P, Adriaensen P. OHSS Free Clinic. Facts Views Vision 2011; 3:43-45.
21. Devroey P, Aboulghar M, Garcia-Velasco J, Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Tomás C, Fauser BC. Improving the patient's experience with IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod 2009;24:764-774.
22. DiLuigi AJ, Engmann L, Schmidt DW, Maier DB, Nulsen JC, Benavida CA. Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting. Fertil Steril 2010; 94:1111-1114.
23. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 2008;89:84-91.
24. Fatemi HM, Kyrou D, Bourgain C, Van den Abbeel E, Griesinger G, Devroey P. Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle. Fertil Steril 2010;94:2054-2058.
25. Ferraretti AP, Gianaroli L, Magli C, Fortini D, Selman HA, Feliciani E. Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety. Hum Reprod 1999;14:1457-1460. (Pubitemid 29265433)
26. Fineschi V, Neri M, Di Donato S, Pomara C, Riezzo I, Turillazzi E. An immunohistochemical study in a fatality due to ovarian hyperstimulation syndrome. Int J Legal Med 2006;120:293-299.
27. Fluker M, Grifo J, Leader A, Levy M, Meldrum D, Muasher SJ, Rinehart J, Rosenwaks Z, Scott RT Jr, Schoolcraft W et al. North American Ganirelix Study Group. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 2001;75:38-45. (Pubitemid 32041225)
28. Glujovsky D, Pesce R, Fiszbajn G, Sueldo C, Hart RJ, Ciapponi A. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev 2010;20:CD006359.
29. Gonen Y, Balakier H, Powell W, Casper RF. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilisation. J Clin Endocrinol Metab 1990;71:918-922.
30. Griesinger G, von Otte S, Schroer A, Ludwig AK, Diedrich K, Al-Hasani S, Schultze-Mosgau A. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum Reprod 2007;22:1348-1352. (Pubitemid 47062805)
31. Heng BC. Oocyte cryopreservation as alternative to embryo cryopreservation-some pertinent ethical concerns. Reprod Biomed Online 2007;14:402-403. (Pubitemid 46463641)
32. Herrero L, Pareja S, Losada C, Cobo AC, Pellicer A, Garcia-Velasco JA. Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome. Fertil Steril 2011;95:1137-1140.
33. Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, Andersen CY. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomised study. Hum Reprod 2005;20:1213-1220. (Pubitemid 40796107)
34. Humaidan P, Bungum L, Bungum M, Yding Andersen C. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 2006;13:173-178. (Pubitemid 44207763)
35. Humaidan P, Papanikolaou EG, Tarlatzis BC. GnRHa to trigger final oocyte maturation: a time to reconsider. Hum Reprod 2009;24:2389-2394.
36. Humaidan P, Ejdrup Bredkjaer H, Westergaard LG, Yding Andersen C. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomised, controlled study. Fertil Steril 2010;93:847-854.
37. Itskovitz J, Boldes R, Levron J, Erlik Y, Kahana L, Brandes J. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril 1991;56:213-220.
38. Kim TJ, Laufer LR, Hong SW. Vitrification of oocytes produces high pregnancy rates when carried out in fertile women. Fertil Steril 2010; 93:467-474.
39. Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 2006;12:651-671. (Pubitemid 44605507)
40. Kolibianakis EM, Papanikolaou EG, Tournaye H, Camus M, Van Steirteghem AC, Devroey P. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomised pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone. Fertil Steril 2007;88:1382-1388. (Pubitemid 350030972)
41. Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficiënt vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005;11:300-308. (Pubitemid 41269568)
42. Lambalk CB, Leader A, Olivennes F, Fluker MR, Andersen AN, Ingerslev J, Khalaf Y, Avril C, Belaisch-Allart J, Roulier R et al. Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Hum Reprod 2006; 21:632-639. (Pubitemid 43372966)
43. Melo M, Busso CE, Bellver J, Alama P, Garrido N, Meseguer M, Pellicer A, Remoh́ý J. GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomised, prospective, controlled, assessor-blind study. Reprod Biomed Online 2009;19:486-492.
44. Nachtigall RD, Mac Dougall K, Lee M, Harrington J, Becker G. What do patients want? Expectations and perceptions of IVF clinic information and support regarding frozen embryo disposition. Fertil Steril 2010; 94:2069-2072.
45. Nagy ZP, Chang CC, Shapiro DB, Bernal DP, Kort HI, Vajta G. The efficacy and safety of human oocyte vitrification. Semin Reprod Med 2009;27:450-455.
46. Papanikolaou EG, Tournaye H, Verpoest W, Camus M, Vernaeve V, Van Steirteghem A, Devroey P. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod 2005; 20:636-641. (Pubitemid 40425488)
47. Reissmann T, Schally AV, Bouchard P, Riethmiiller H, Engel J. The LHRH antagonist cetrorelix: a review. Hum Reprod Update 2000;6:322-331. (Pubitemid 30657786)
48. Rienzi L, Romana S, Albricci L, Maggiulli R, Capalbo A, Baroni E, Colamaria S, Sapienza F, Ubaldi F. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomised sibling-oocyte study. Hum Reprod 2010;25:66-73.
49. Segal S, Casper RF. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilisation. Fertil Steril 1992;57:1254-1258.
50. Selman H, Brusco GF, Fiorini F, Barnocchi N, Mariani M, El-Danasouri I. Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilisation patients at high risk of developing ovarian hyperstimulation syndrome. Fertil Steril 2009;91:1611-1613.
51. Semba S, Moriya T, Youssef EM, Sasano H. An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion. Pathol Int 2000;50:549-552. (Pubitemid 30609864)
52. Shalev E, Geslevich Y, Ben-Ami M. Induction of pre-ovulatory luteinizing hormone surge by gonadotrophin-releasing hormone agonist for women at risk for developing the ovarian hyperstimulation syndrome. Hum Reprod 1994;9:417-419. (Pubitemid 24096392)
53. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Ross R, Morris S. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilisation. Fertil Steril 2005;84:93-98. (Pubitemid 40991466)
54. Surrey E, Keller J, Stevens J, Gustofson R, Minjarez D, Schoolcraft W. Freeze-all: enhanced outcomes with cryopreservation at the blastocyst stage versus pronuclear stage using slow-freeze techniques. Reprod Biomed Online 2010;21:411-417.
55. Tarlatzis BC, Kolibianakis EM. GnRH agonists vs antagonists. Best Pract Res Clin Obstet Gynaecol 2007;21:57-65.
56. Verberg MF, Eijkemans MJ, Heijnen EM, Broekmans FJ, de Klerk C, Fauser BC, Macklon NS. Why do couples drop-out from IVF treatment? A prospective cohort study. Hum Reprod 2008;23:2050-2055.
57. Wikland M, Borg J, Forsberg AS, Jakobsson AH, Svalander P, Waldenström U. Human chorionic gonadotrophin self-administered by the subcutaneous route to induce oocyte maturation in an in-vitro fertilisation and embryo transfer programme. Hum Reprod 1995; 10:1667-1670.